Supports Natural Cell Repair: Your cells renew constantly
Since control of diabetes and obesity are significant health outcome risk factors, it is conceivable that the shortages and high cost of GLP1 agonists will exacerbate existing health disparities. David Cutler, MD His perspective echoed what Ma told us, namely that [o]ne of the biggest bottlenecks with GLP-1RA access is cost and insurance. Even if a doctor prescribes [this type of drug], patients cannot obtain it if their insurance does not cover it, which could worsen disparities, especially for those with public insurance or in underserved populations, he also emphasized
Early observational data support this possibility, with some patients reporting fewer nodules and less drainage over time
Bottom line: side effects live next to dose day, food, and weight, so a rough day reads as part of the week instead of a symptom in isolation
By mimicking the effects of the naturally occurring GLP-1 hormone, these injections help the body recognize when it is full, reducing the desire to eat more food
